Library
2-NMC
2-NMC (BMAPN) is a synthetic cathinone with a naphthalene ring substitution that exhibits potent dopaminergic activity and abuse potential in animal models. Virtually no controlled human pharmacology data exists. Animal studies indicate it produces locomotor sensitization, decreases dopamine transporter expression, and increases dopamine D2 receptor gene expression in the striatum. Often mis-sold as 'NRG-3' (a brand name that typically contained MDPV or α-PVP instead). Marked nasal mucosa irritation when insufflated; eye/airway irritation when vaporized.
Also known as: Bmapn, Βk-methamnetamine, 2‑naphthyl‑N‑methylcathinone, 2‑naphthylmethcathinone
Classification
- Chemical: Cathinone
- Tag: Habit-Forming
- Tag: Inactive
- Tag: Naphthylaminopropane
- Tag: Research-Chemical
Effects
- Stimulation
- Pupil Dilation
- Increased Heart Rate
- Vasoconstriction
- Perspiration
- Jaw Tension And Bruxism
- Euphoria
- Increased Motivation
- Empathy And Sociability
- Talkativeness
- Enhanced Music Appreciation
- Anxiety
- Sexual Arousal
- Increased Libido
- Increased Music Appreciation
Routes of Administration
Oral
Dosage
- Threshold: 10 mg
- Light: 25 – 50 mg
- Common: 50 – 120 mg
- Strong: 120 – 180 mg
- Heavy: 180 + mg
Duration
- Onset: 0.25-0.58 h
- Comeup: 0.5-1 h
- Peak: 1-2.5 h
- Offset: 2.5-4 h
- After Effects: 4-10 h
- Total Duration: 3-6 h
Insufflated
Dosage
- Threshold: 5 mg
- Light: 15 – 25 mg
- Common: 25 – 60 mg
- Strong: 60 – 90 mg
- Heavy: 90 + mg
Duration
- Onset: 0.03-0.08 h
- Comeup: 0.08-0.25 h
- Peak: 0.5-1.5 h
- Offset: 1.5-3 h
- After Effects: 2-6 h
- Total Duration: 2-4 h
Vaporized
Dosage
- Threshold: <5 mg
- Light: 5 – 10 mg
- Common: 10 – 20 mg
- Strong: 20 – 30 mg
- Heavy: 30 + mg
Duration
- Onset: 0.01-0.03 h
- Comeup: 0.03-0.08 h
- Peak: 0.5-1.5 h
- Offset: 0.5-1 h
- After Effects: 2-4 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
